Ayala Pharmaceuticals Inc (STU:FAD)
€ 0.01 -0.04 (-80%) Market Cap: 788,000.00 Enterprise Value: 3.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

Advaxis Inc Extraordinary Shareholders Meeting Transcript

Dec 16, 2021 / 03:00PM GMT
Operator

Good day, and welcome to the Advaxis Second Reconvened Special Meeting of Shareholders. I would now like to turn the conference over to Kenneth Berlin, CEO of Advaxis. Please go ahead.

Kenneth A. Berlin
Advaxis, Inc. - President, Interim CFO, CEO & Director

Good morning. I'm Kenneth Berlin, Chief Executive Officer of Advaxis, Inc. Welcome, and thank you for joining us for the second Reconvened Special Meeting of Stockholders. As the company has reported previously in its filings with the Securities and Exchange Commission, a reconvened special meeting of stockholders held on December 7, 2021, the share issuance proposal and compensation proposals submitted to stockholders for vote were both approved. As authorized by the adjournment proposal approved on November 16, 2021, the reconvened special meeting of stockholders was partially adjourned in order to solicit additional proxies to vote in favor of proposals 2 and 3. Accordingly, the polls with respect to proposals 2 and 3 remained open following our reconvened special meeting of stockholders held on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot